Israel
· Delayed Price · Currency is ILS · Price in ILASofWave Medical Statistics
Total Valuation
SofWave Medical has a market cap or net worth of ILS 584.94 million. The enterprise value is 510.53 million.
| Market Cap | 584.94M |
| Enterprise Value | 510.53M |
Important Dates
The last earnings date was Wednesday, November 6, 2024.
| Earnings Date | Nov 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SofWave Medical has 34.41 million shares outstanding. The number of shares has increased by 0.29% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 34.41M |
| Shares Change (YoY) | +0.29% |
| Shares Change (QoQ) | +0.07% |
| Owned by Insiders (%) | 36.61% |
| Owned by Institutions (%) | 16.57% |
| Float | 12.82M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.77 |
| PB Ratio | 6.47 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -32.56 |
| EV / Sales | 2.42 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -54.72 |
Financial Position
The company has a current ratio of 2.43, with a Debt / Equity ratio of 0.05.
| Current Ratio | 2.43 |
| Quick Ratio | 2.05 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.49 |
| Interest Coverage | -16.21 |
Financial Efficiency
Return on equity (ROE) is -16.68% and return on invested capital (ROIC) is -8.57%.
| Return on Equity (ROE) | -16.68% |
| Return on Assets (ROA) | -5.67% |
| Return on Capital (ROIC) | -8.57% |
| Revenue Per Employee | 1.80M |
| Profits Per Employee | -134,013 |
| Employee Count | 117 |
| Asset Turnover | 1.41 |
| Inventory Turnover | 2.84 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +37.84% in the last 52 weeks. The beta is 0.60, so SofWave Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.60 |
| 52-Week Price Change | +37.84% |
| 50-Day Moving Average | 1,816.74 |
| 200-Day Moving Average | 1,757.50 |
| Relative Strength Index (RSI) | 36.31 |
| Average Volume (20 Days) | 20,708 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SofWave Medical had revenue of ILS 210.53 million and -15.68 million in losses. Loss per share was -0.46.
| Revenue | 210.53M |
| Gross Profit | 158.69M |
| Operating Income | -13.56M |
| Pretax Income | -14.70M |
| Net Income | -15.68M |
| EBITDA | -10.08M |
| EBIT | -13.56M |
| Loss Per Share | -0.46 |
Balance Sheet
The company has 78.99 million in cash and 4.58 million in debt, giving a net cash position of 74.41 million or 2.16 per share.
| Cash & Cash Equivalents | 78.99M |
| Total Debt | 4.58M |
| Net Cash | 74.41M |
| Net Cash Per Share | 2.16 |
| Equity (Book Value) | 90.21M |
| Book Value Per Share | 2.63 |
| Working Capital | 77.00M |
Cash Flow
In the last 12 months, operating cash flow was -8.35 million and capital expenditures -981,367, giving a free cash flow of -9.33 million.
| Operating Cash Flow | -8.35M |
| Capital Expenditures | -981,367 |
| Free Cash Flow | -9.33M |
| FCF Per Share | -0.27 |
Margins
Gross margin is 75.38%, with operating and profit margins of -6.44% and -7.45%.
| Gross Margin | 75.38% |
| Operating Margin | -6.44% |
| Pretax Margin | -6.98% |
| Profit Margin | -7.45% |
| EBITDA Margin | -4.79% |
| EBIT Margin | -6.44% |
| FCF Margin | -4.43% |
Dividends & Yields
SofWave Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.29% |
| Shareholder Yield | -0.29% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |